Increased Insulin Requirements in Severe Cases of Covid-19 are Higher Than in Moderate Cases
Patients with severe COVID-19 required a significantly higher maximum insulin dose than did those with moderate COVID-19. The maximum insulin dose was reached approximately 2 weeks after onset. Furthermore, the hemoglobin A1c level on admission and the use of a ventilator or extracorporeal membrane oxygenation during hospitalization were associated with the need for maximum insulin dose.
Authors
- Yuka Hasegawa
- Masahiro Yamazaki (ORCID: https://orcid.org/0000-0001-6293-3525)
- Teiji Sawa (ORCID: https://orcid.org/0000-0001-9558-9011)
- Takaaki Matsui (ORCID: https://orcid.org/0000-0003-4459-2231)
- Emi Ushigome (ORCID: https://orcid.org/0000-0003-1031-4380)
- Yuriko Kondo
- Dan Imai
- Kazuki Sudo
- Michiaki Fukui (ORCID: https://orcid.org/0000-0003-0903-1797)
- Masahide Hamaguchi (ORCID: https://orcid.org/0000-0002-8651-4445)
- Nobuko Kitagawa
- Tomohiro Hattori
Institutions
- Kyoto Prefectural University of Medicine (JP)
Publication Details
- Journal
- Diabetes Metabolic Syndrome and Obesity
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/dmso.s480598
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00